| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Medtronic plc | $110.1b | $86.55 | -0.1% | 1.4M | |
| Edwards Lifesciences Corp | $45.8b | $81.23 | +0.2% | 945.1K | |
| Alcon Inc. Ordinary Shares | $35.9b | $74.45 | -0.1% | 238.0K | |
| Biogen Inc. Common Stock | $27.5b | $174.03 | -1.9% | 603.6K | |
| Zimmer Biomet Holdings, Inc. | $17.3b | $90.93 | +0.0% | 308.4K | |
| Glaukos Corporation | $6.1b | $114.36 | +1.4% | 237.0K | |
| Bausch + Lomb Corporation | $5.4b | $16.39 | -0.6% | 138.5K | |
| Denali Therapeutics Inc. Common Stock | $2.9b | $19.98 | -3.3% | 772.0K | |
| BioAge Labs, Inc. Common Stock | $0.7b | $17.54 | +0.2% | 89.4K | |
| Bioventus Inc. Class A Common Stock | $0.6b | $9.05 | +0.9% | 193.8K | |
| Anteris Technologies Global Corp. Common Stock | $496.9m | $5.34 | -2.8% | 256.4K | |
| AC Immune SA | $260.5m | $2.75 | -0.4% | 44.8K | |
| LENZ Therapeutics, Inc. Common Stock | $259.9m | $9.61 | -0.6% | 163.2K | |
| Alector, Inc. Common Stock | $222.9m | $2.44 | +1.0% | 333.5K | |
| Acumen Pharmaceuticals, Inc. Common Stock | $158.1m | $2.71 | +0.4% | 276.7K | |
| Alpha Cognition Inc. Common Stock | $115.7m | $6.29 | +5.2% | 24.8K | |
| Annovis Bio, Inc. | $57.0m | $2.38 | +4.4% | 1.1M | |
| Cognition Therapeutics, Inc. Common Stock | $53.1m | $0.85 | -2.0% | 509.6K | |
| Envoy Medical, Inc. Class A Common Stock | $49.4m | $0.73 | -2.2% | 84.4K | |
| Telomir Pharmaceuticals, Inc. Common Stock | $39.2m | $1.28 | +1.2% | 18.0K | |
| Greenland Mines Ltd. Common Stock | $33.7m | $0.32 | -12.1% | 2.1M | |
| CervoMed Inc. Common Stock | $33.5m | $4.04 | -2.3% | 11.5K | |
| Longeveron Inc. Common Stock | $27.2m | $1.09 | +1.9% | 407.9K | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $24.4m | $0.78 | -5.7% | 246.2K | |
| Outlook Therapeutics, Inc. Common Stock | $21.0m | $0.20 | -7.8% | 1.4M | |
| 20/20 Biolabs, Inc. Common Stock | $18.4m | $1.96 | +6.8% | 23.3K | |
| OSR Holdings, Inc. Common Stock | $13.6m | $0.51 | -7.0% | 196.9K | |
| FibroBiologics, Inc. Common Stock | $8.0m | $1.43 | +3.3% | 178.4K | |
| Alzamend Neuro, Inc. Common Stock | $4.0m | $1.02 | +2.0% | 27.7K | |
| HCW Biologics Inc. Common Stock | $1.3m | $0.27 | +2.3% | 160.2K |